| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $1,145,114 ) |
| | 2024 | 2024 | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. | 12902 MAGNOLIA DR | TAMPA | FL | 33612-9416 | HILLSBOROUGH | USA | R01CA269721 | Role of ULK3 in Sensitive and Refractory Multiple Myeloma | 000 | 2 | NIH | 11/3/2023 | $482,202 |
| | 2024 | 2024 | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. | 12902 MAGNOLIA DR | TAMPA | FL | 33612-9416 | HILLSBOROUGH | USA | R03AI175796 | The role of HPV E1 in regulating the NRF2-KEAP1 pathway | 000 | 2 | NIH | 11/20/2023 | $75,825 |
| | 2024 | 2024 | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. | 12902 MAGNOLIA DR | TAMPA | FL | 33612-9416 | HILLSBOROUGH | USA | R03CA286682 | Targeting ULK3 for the treatment of triple negative breast cancer | 000 | 1 | NIH | 11/23/2023 | $84,250 |
| | 2024 | 2024 | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. | 12902 MAGNOLIA DR | TAMPA | FL | 33612-9416 | HILLSBOROUGH | USA | R01CA231952 | Partnering with a State Food Bank to Provide Tobacco Treatment to Underserved Smokers | 000 | 6 | NIH | 11/9/2023 | $502,837 |
| | 2024 | 2023 | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. | 12902 MAGNOLIA DR | TAMPA | FL | 33612-9416 | HILLSBOROUGH | USA | CE152205 | Community Project Funding/Congressionally Directed Spending - Construction | 02 | 1 | HRSA | 11/8/2023 | $0 |
| | 2024 | 2023 | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. | 12902 MAGNOLIA DR | TAMPA | FL | 33612-9416 | HILLSBOROUGH | USA | CE152205 | Community Project Funding/Congressionally Directed Spending - Construction | 01 | 1 | HRSA | 11/1/2023 | $0 |
| | 2024 | 2023 | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. | 12902 MAGNOLIA DR | TAMPA | FL | 33612-9416 | HILLSBOROUGH | USA | CE152143 | Community Project Funding/Congressionally Directed Spending - Construction | 03 | 1 | HRSA | 11/16/2023 | $0 |
| | 2024 | 2023 | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. | 12902 MAGNOLIA DR | TAMPA | FL | 33612-9416 | HILLSBOROUGH | USA | CE152143 | Community Project Funding/Congressionally Directed Spending - Construction | 02 | 1 | HRSA | 11/8/2023 | $0 |
| | 2024 | 2023 | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. | 12902 MAGNOLIA DR | TAMPA | FL | 33612-9416 | HILLSBOROUGH | USA | CE152143 | Community Project Funding/Congressionally Directed Spending - Construction | 01 | 1 | HRSA | 11/2/2023 | $0 |
| | 2024 | 2023 | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. | 12902 MAGNOLIA DR | TAMPA | FL | 33612-9416 | HILLSBOROUGH | USA | CE152205 | Community Project Funding/Congressionally Directed Spending - Construction | 03 | 1 | HRSA | 11/16/2023 | $0 |
| | 2024 | 2022 | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. | 12902 MAGNOLIA DR | TAMPA | FL | 33612-9416 | HILLSBOROUGH | USA | CE145995 | Community Project Funding/Congressionally Directed Spending - Construction | 04 | 1 | HRSA | 11/16/2023 | $0 |
| | 2024 | 2021 | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. | 12902 MAGNOLIA DR | TAMPA | FL | 33612-9416 | HILLSBOROUGH | USA | R01CA212169 | Augmenting T cell trafficking and functionality through novel combinations of epigenetic agents and PD-1 blockade | 000 | 5 | NIH | 11/22/2023 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $61,707,076 ) (Continued on the next page) |
| | 2023 | 2023 | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. | 12902 MAGNOLIA DR | TAMPA | FL | 33612-9416 | HILLSBOROUGH | USA | R01CA279713 | RBFOX2 deregulation promotes pancreatic cancer progression through alternative splicing | 000 | 1 | NIH | 4/10/2023 | $469,135 |
| | 2023 | 2023 | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. | 12902 MAGNOLIA DR | TAMPA | FL | 33612-9416 | HILLSBOROUGH | USA | R01CA278300 | The impact of inflammation on HSPC composition and disease progression in chronic myelomonocytic leukemia | 000 | 1 | NIH | 3/7/2023 | $636,099 |
| | 2023 | 2023 | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. | 12902 MAGNOLIA DR | TAMPA | FL | 33612-9416 | HILLSBOROUGH | USA | R03CA259873 | A framework to integrate live-cell imaging with single-cell sequencing and learn how cells adapt to new environments | 000 | 2 | NIH | 12/2/2022 | $81,686 |
| | 2023 | 2023 | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. | 12902 MAGNOLIA DR | TAMPA | FL | 33612-9416 | HILLSBOROUGH | USA | R01CA256193 | Characterization and targeting of the epigenetic state underlying uveal melanoma liver metastasis | 000 | 3 | NIH | 7/27/2023 | $638,384 |
| | 2023 | 2023 | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. | 12902 MAGNOLIA DR | TAMPA | FL | 33612-9416 | HILLSBOROUGH | USA | R01CA255265 | Efficacy of a Mindfulness-Based Stress Management Program for Allogeneic HCT Caregivers | 000 | 3 | NIH | 3/13/2023 | $579,443 |
| | 2023 | 2023 | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. | 12902 MAGNOLIA DR | TAMPA | FL | 33612-9416 | HILLSBOROUGH | USA | R01CA249689 | CARES-REACH (Colorectal Cancer Awareness, Research, Education and Screening-Rural Expansion, Access and Capacity for Health) | 001 | 4 | NIH | 3/1/2023 | $79,932 |
| | 2023 | 2023 | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. | 12902 MAGNOLIA DR | TAMPA | FL | 33612-9416 | HILLSBOROUGH | USA | U54CA277834 | Partnership to Assess Viral and Immune Landscape Intersections with ONcology for People Living with HIV (PAVILION) | 000 | 1 | NIH | 8/3/2023 | $1,224,501 |
| | 2023 | 2023 | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. | 12902 MAGNOLIA DR | TAMPA | FL | 33612-9416 | HILLSBOROUGH | USA | R01CA269721 | Role of ULK3 in Sensitive and Refractory Multiple Myeloma | 000 | 1 | NIH | 12/16/2022 | $537,178 |
| | 2023 | 2023 | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. | 12902 MAGNOLIA DR | TAMPA | FL | 33612-9416 | HILLSBOROUGH | USA | R21CA267291 | Characterization of the oncogenic potential of circRNAs in melanoma | 001 | 2 | NIH | 3/14/2023 | $15,755 |
| | 2023 | 2023 | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. | 12902 MAGNOLIA DR | TAMPA | FL | 33612-9416 | HILLSBOROUGH | USA | K08CA255933 | Role of the Chromosome 19 MicroRNA Cluster in Liver Cancers | 000 | 3 | NIH | 7/17/2023 | $248,813 |
| | 2023 | 2023 | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. | 12902 MAGNOLIA DR | TAMPA | FL | 33612-9416 | HILLSBOROUGH | USA | R01CA249016 | Radiomics and Pathomics to predict upstaging of DCIS | 000 | 3 | NIH | 6/7/2023 | $669,313 |
| | 2023 | 2023 | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. | 12902 MAGNOLIA DR | TAMPA | FL | 33612-9416 | HILLSBOROUGH | USA | R01CA249689 | CARES-REACH (Colorectal Cancer Awareness, Research, Education and Screening-Rural Expansion, Access and Capacity for Health) | 000 | 4 | NIH | 2/28/2023 | $609,630 |
| | 2023 | 2023 | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. | 12902 MAGNOLIA DR | TAMPA | FL | 33612-9416 | HILLSBOROUGH | USA | R01CA276224 | The role of biobehavioral factors and anti-inflammatory medications on the ovarian tumor immune response | 000 | 1 | NIH | 9/19/2023 | $727,575 |
| | 2023 | 2023 | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. | 12902 MAGNOLIA DR | TAMPA | FL | 33612-9416 | HILLSBOROUGH | USA | R21CA267291 | Characterization of the oncogenic potential of circRNAs in melanoma | 000 | 2 | NIH | 12/7/2022 | $177,242 |
| | 2023 | 2023 | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. | 12902 MAGNOLIA DR | TAMPA | FL | 33612-9416 | HILLSBOROUGH | USA | R21CA267141 | Defining and targeting the epigenetic programs involved in melanoma development | 000 | 2 | NIH | 2/10/2023 | $192,997 |
| | 2023 | 2023 | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. | 12902 MAGNOLIA DR | TAMPA | FL | 33612-9416 | HILLSBOROUGH | USA | R01NS117926 | Elucidating the epigenetic landscape of neurofibromatosis and development of therapeutic targets | 000 | 3 | NIH | 8/23/2023 | $411,392 |
| | 2023 | 2023 | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. | 12902 MAGNOLIA DR | TAMPA | FL | 33612-9416 | HILLSBOROUGH | USA | R01CA255398 | Characterizing oncogenic function of ITCH in melanoma | 000 | 3 | NIH | 8/25/2023 | $369,216 |
| | 2023 | 2023 | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. | 12902 MAGNOLIA DR | TAMPA | FL | 33612-9416 | HILLSBOROUGH | USA | R01CA258089 | Eco-evolutionary drivers of clonal dynamics during UV-induced skin carcinogenesis (PQ3) | 000 | 3 | NIH | 3/20/2023 | $627,220 |
| | 2023 | 2023 | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. | 12902 MAGNOLIA DR | TAMPA | FL | 33612-9416 | HILLSBOROUGH | USA | R01CA241169 | Understanding the influence of bone-metastatic prostate cancer and mesenchymal stromal cells on ?? T cells, in the bone microenvironment. | 000 | 4 | NIH | 2/28/2023 | $462,850 |
| | 2023 | 2023 | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. | 12902 MAGNOLIA DR | TAMPA | FL | 33612-9416 | HILLSBOROUGH | USA | R21AG083720 | Adaptations of breast cancer metastasis to the aging lung | 000 | 1 | NIH | 8/18/2023 | $210,625 |
| | 2023 | 2023 | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. | 12902 MAGNOLIA DR | TAMPA | FL | 33612-9416 | HILLSBOROUGH | USA | R01CA275974 | Methylomic basis of survival disparities among Black and White women with high-grade serous ovarian cancer | 000 | 1 | NIH | 1/19/2023 | $706,049 |
| | 2023 | 2023 | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. | 12902 MAGNOLIA DR | TAMPA | FL | 33612-9416 | HILLSBOROUGH | USA | R21CA259215 | Molecular Drivers of Lung Cancer in Hispanics | 001 | 2 | NIH | 3/14/2023 | $15,755 |
| | 2023 | 2023 | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. | 12902 MAGNOLIA DR | TAMPA | FL | 33612-9416 | HILLSBOROUGH | USA | R01CA262530 | Developing CDK12 inhibitors to overcome therapy resistance in HER2+ and KRAS driven breast and lung cancers | 000 | 3 | NIH | 8/4/2023 | $666,289 |
| | 2023 | 2023 | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. | 12902 MAGNOLIA DR | TAMPA | FL | 33612-9416 | HILLSBOROUGH | USA | R01DE030493 | Investigating the prognostic role of intrinsic immune evasion mechanisms in HNSCC | 000 | 3 | NIH | 3/29/2023 | $390,669 |
| | 2023 | 2023 | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. | 12902 MAGNOLIA DR | TAMPA | FL | 33612-9416 | HILLSBOROUGH | USA | R01CA259387 | Mathematical Model-Guided Adoptive Immunotherapy in Bladder Cancer | 000 | 3 | NIH | 2/24/2023 | $466,517 |
| | 2023 | 2023 | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. | 12902 MAGNOLIA DR | TAMPA | FL | 33612-9416 | HILLSBOROUGH | USA | R01CA233601 | Transcriptional and Epigenetic Adaptation as Novel Therapeutic Vulnerabilities for Mantle Cell Lymphoma | 000 | 4 | NIH | 3/1/2023 | $487,253 |
| | 2023 | 2023 | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. | 12902 MAGNOLIA DR | TAMPA | FL | 33612-9416 | HILLSBOROUGH | USA | R33NS119658 | Employing functionalized fragment libraries to identify therapeutic agents for neurofibromatosis type 2 | 000 | 3 | NIH | 5/25/2023 | $415,703 |
| | 2023 | 2023 | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. | 12902 MAGNOLIA DR | TAMPA | FL | 33612-9416 | HILLSBOROUGH | USA | R21CA269415 | Engineering model-based systems to monitor and steer subclonal dynamics | 000 | 1 | NIH | 4/26/2023 | $236,321 |
| | 2023 | 2023 | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. | 12902 MAGNOLIA DR | TAMPA | FL | 33612-9416 | HILLSBOROUGH | USA | R21CA277288 | Integrated fragment-based phenotypic screening and chemoproteomics for identification of novel small cell lung cancer-specific targets | 000 | 1 | NIH | 2/2/2023 | $236,321 |
| | 2023 | 2023 | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. | 12902 MAGNOLIA DR | TAMPA | FL | 33612-9416 | HILLSBOROUGH | USA | R21CA259215 | Molecular Drivers of Lung Cancer in Hispanics | 000 | 2 | NIH | 12/28/2022 | $177,242 |
| | 2023 | 2023 | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. | 12902 MAGNOLIA DR | TAMPA | FL | 33612-9416 | HILLSBOROUGH | USA | R01CA262530 | Developing CDK12 inhibitors to overcome therapy resistance in HER2+ and KRAS driven breast and lung cancers | 001 | 3 | NIH | 8/7/2023 | $72,662 |
| | 2023 | 2023 | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. | 12902 MAGNOLIA DR | TAMPA | FL | 33612-9416 | HILLSBOROUGH | USA | R01HL151579 | Targeting altered phosphatase-dependent signaling to overcome the inefficacy of targeted therapy in myeloproliferative neoplasms | 000 | 3 | NIH | 2/15/2023 | $477,968 |
| | 2023 | 2023 | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. | 12902 MAGNOLIA DR | TAMPA | FL | 33612-9416 | HILLSBOROUGH | USA | R01CA279065 | Spatial and Bayesian modeling methods for assessment of the tumor immune microenvironment and survival of women with ovarian cancer | 000 | 1 | NIH | 4/17/2023 | $574,038 |
| | 2023 | 2023 | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. | 12902 MAGNOLIA DR | TAMPA | FL | 33612-9416 | HILLSBOROUGH | USA | R21ES035196 | Novel role of melanin-carbonyls in progression of NRAS mutant melanoma | 000 | 1 | NIH | 7/21/2023 | $463,375 |
| | 2023 | 2023 | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. | 12902 MAGNOLIA DR | TAMPA | FL | 33612-9416 | HILLSBOROUGH | USA | R03AI175796 | The role of HPV E1 in regulating the NRF2-KEAP1 pathway | 000 | 1 | NIH | 1/19/2023 | $84,250 |
| | 2023 | 2023 | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. | 12902 MAGNOLIA DR | TAMPA | FL | 33612-9416 | HILLSBOROUGH | USA | R21CA267283 | Developing GRB2-PROTACs for Treatment of Lung Cancer | 000 | 1 | NIH | 12/9/2022 | $236,321 |
|
